Multidrug resistance of Pseudomonas aeruginosa as known from surveillance of nosocomial and community infections in an Indian teaching hospital

Journal of Public Health (Germany)

Volumn 20, Issue 4, 2012, Pages 413-423

  Sahu, Mahesh C ^a   Dubey, Debasmita ^a   Rath, Shakti ^a   Debata, Nagen K ^a   Padhy, Rabindra N ^b  

^a SIKSHA O ANUSANDHAN DEEMED TO BE UNIVERSITY   (India)

^b B J B Autonomous College   (India)

Author keywords

Antibiotic sensitivity; Community; ES L strains; Nosocomial infections; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; GATIFLOXACIN; GENTAMICIN; LEVOFLOXACIN; NETILMICIN; NORFLOXACIN; OFLOXACIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; MULTIDRUG RESISTANCE; NEWBORN INTENSIVE CARE; OUTPATIENT DEPARTMENT; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; TEACHING HOSPITAL; URINALYSIS; WARD;

EID: 84860136217     PISSN: 09431853     EISSN: 16132238     Source Type: Journal    
DOI: 10.1007/s10389-011-0479-2     Document Type: Article

References (58)

1. Adwan K, Abu-Hasan N, Adwan G, Jarrar N, Abu-Shanab B, Al-Masri M (2004) Molecular epidemiology of antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections in Northern Palestine. Pol J Microbiol 53:23-26
2. Alekshun MN, Levy SB (1999) The mar regulon: multiple resistance to antibiotics and other toxic chemicals. Trends Microbiol 7:410-413
3. Aminizadeh Z, Kashi MS (2011) Prevalence of multi-drug resistance and pandrug resistance among multiple gram-negative species: experience in one teaching hospital, Tehran, Iran. Int Res J Microbiol 2:90-95
4. Arenstein AW, Cross SA (1993) Local and disseminated disease caused by Pseudomonas aeruginosa. In: Mario C, Mauro B, Herman F (eds) Pseudomonas aeruginosa as an opportunistic pathogen. Plenum, New York, pp 223-244
5. Askarian M, Hossseini R, Kheirandish P et al (2004) Incidence and outcome of nosocomial infections in female burn patients in Shiraz, Iran. Am J Infect Control 32:23-26
6. Bantar C, Chiara M, Nicola F, Relloso S, Smayevsky J (2000) Comparative in vitro bactericidal activity between cefepime and ceftazidime, alone and associated with amikacin, against carbapenemresistant Pseudomonas aeruginosa strains. Diagn Microbiol Infect Dis 37:41-44
7. Bauer AM, Kirby WMM, Sherris JC, Turck M (1966) Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 45:493-496
8. Bradford PA (2001) Extended spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 14:933-954
9. Bukharie HA, Mowafi HA (2010) Antimicrobial susceptibility pattern of Pseudomonas aeruginosa and antibiotic use in King Fahd hospital of the University in Khobar, Saudi Arabia. Sci J King Faisal Univ (Basic and Appl Sci) 11:185-191
10. Burns JL, Clark DK (1992) Salicylate-inducible antibiotic resistance in Pseudomonas cepacia associated with absence of a pore-forming outer membrane protein. Antimicrob Agents Chemother 36:2280-2285
11. Buttery JP, Alabaster SJ, Heine RG, Scott SM, Crutchfield RA, Bigham A, Tabrizi SN, Garland SM (1998) Multiresistant Pseudomonas aeruginosa outbreak in a pediatric oncology ward related to bath toys. Pediatr Infect Dis J 17:509-513
12. Carson LA, Favero MS, Bond WW, Petersen NJ (1972) Factors affecting comparative resistance of naturally occurring and subcultured Pseudomonas aeruginosa to disinfectants. Appl Environ Microbiol 23:863-869
13. Chakrabarty AM (1974) Dissociation of a degradative plasmid aggregate in Pseudomonas. J Bacteriol 118:815-820
14. Cross DF, Benchimol A, Dimond EG (1966) The faucet aerator - a source of pseudomonas infection. N Engl J Med 274:1430-1431
15. Ekrami A, Kalantar E (2007) Bacterial infections in burn patients at a burn hospital in Iran. Indian J Med Res 126:541-544
16. Espiritu C (2008) Treatment and prevention of ocular bacterial infections in Asia part II: the changing landscape of antibiotic treatment. Asian J Ophthalmol 10:388-394
17. Falagas ME, Bliziotis IA (2007) Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era? Int J Antimicrob Agents 29:630-636
18. Ferrari R, Magnani M, Souza RB, Tognim MCB, Oliveira TCRM (2011) Mutant prevention concentration (MPC) of ciprofloxacin against Salmonella enterica of epidemic and poultry origin. Curr Microbiol 62:628-632. doi:10.1007/s00284-010- 9754-9757
19. Forbes BA, Sahm DF, Weissfeld AS (2002) Bailey and Scott's diagnostics in microbiology. Elsevier/Mosby, Maryland Heights, pp 1-783
20. George AM, Levy SB (1983) Gene in the major cotransduction gap of the Escherichia coli K-12 linkage map required for the expression of chromosomal resistance to tetracycline and other antibiotics. J Bacteriol 155:541-548
21. Giamarellos-Bourboulis EJ, Papadimitriou E, Galanakis N, Antonopoulou A, Tsaganos T, Kanellakopoulou K et al (2006) Multidrug resistance to antimicrobials as a predominant factor influencing patient survival. Int J Antimicrob Agents 27:476-481
22. Giamarellou H (2002) Prescribing guidelines for severe Pseudomonas infections. J Antimicrob Chemother 49:229-233
23. Gold HS, Moellering RC (1996) Antimicrobial-drug resistance. N Engl J Med 335:1445-1453
24. Gustafson JE, Candelaria PV, Fisher SA, Goodridge JP, Lichocik TM, McWilliams TM, Price CTD, O'Brien FG, Grubb WB (1999) Growth in the presence of salicylate increases fluoroquinolone resistance in Staphylococcus aureus. Antimicrob Agents Chemother 43:990-992
25. Harris A, Torres-Viera C, Venkataraman L, DeGirolami P, Samore M, Carmeli Y (1999) Epidemiology and clinical outcomes of patients with multiresistant Pseudomonas aeruginosa. Clin Infect Dis 28:1128-1133
26. Harris AD, Smith D, Johnson JA, Bradham DD, Roghmann M-C (2002) Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients. Clin Infect Dis 34:340-345
27. Javris WR, Martone WJ (1992) Predominant pathogens in hospital infections. J Antimicrob Chemother 29(Suppl A):19-24
28. Kiska DL, Gilligan PH (2003) Pseudomonas. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH (eds) Manual of clinical microbiology, 8th edn. ASM Press, Washington, DC, pp 719-728
29. Lee K, Yong D, Yum JH et al (2005) Evaluation of Etest MBL for detection of blaIMP-1 and blaVIM-2 allele-positive clinical isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 43:942-924
30. Luksamijarulkul P, Parikumsil N, Poomsuwan V, Konkeaw W (2006) Nosocomial surgical site infection among Photharam Hospital patients with surgery: incidence, risk factors and development of risk screening form. J Med Assoc Thai 89:81-89
31. Manno G, Ugolotti E, Belli ML, Fenu ML, Romano L, Cruciani M (2003) Use of the E test to assess synergy of antibiotic combinations against isolates of Burkholderia cepacia-complex from patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis 22:28-34
32. Mario C, Mauro B, Herman F (eds) (1993) Pseudomonas aeruginosa as an opportunistic pathogen. Plenum, New York
33. Moolenaar RL, Crutcher JM, San Joaquin VH, Sewell LV, Hutwagner LC, Carson LA (2000) A prolonged outbreak of Pseudomonas aeruginosa in a neonatal intensive care unit: did staff fingernails play a role in disease transmission? Infect Control Hosp Epidemiol 21:80-85
34. Morrison AJ, Wenzel RP (1984) Epidemiology of infections due to Pseudomonas aeruginosa. Rev Infect Dis 6:S627-S642
35. NNISS - National Nosocomial Infection Surveillance System (1999) Selected antimicrobial resistant pathogens associated with nosocomial infections in ICU patients, comparison of resistance rates from January-December 1999 with 1994-1998, NNIS System [figure], available at: http://www.cdc.gov/ncidod/hip/ NNIS/ar-surv99
36. Navneeth BV, Sridaran D, Sahay D, Belwadi MR (2002) A preliminary study on metallo-beta-lactamase producing Pseudomonas aeruginosa in hospitalized patients. Indian J Med Res 116:264-267
37. NCCLS - National Committee for Clinical Laboratory Standards (2007) Performance standards for antimicrobial susceptibility testing: eleventh informational supplement. Document M100-S11. NCCLS, Wayne, PA
38. Nouér SA, Nucci M, de-Oliveira MP, Pellegrino FL, Moreira BM (2005) Risk factors for acquisition of multidrug-resistant Pseudomonas aeruginosa producing SPM metallo-β-lactamase. Antimicrob Agents Chemother 49:3663-3667
39. Orencia MC, Yoon JS, Ness JE, Stemmer WP, Stevens RC (2001) Predicting the emergence of antibiotic resistance by directed evolution and structural analysis. Nat Struct Biol 8:238-242
40. Pennington JE, Reynolds HY, Carbone PP (1973) Pseudomonas pneumonia: a retrospective study of 36 cases. Am J Med 55:155-160
41. Pitt TL (1990) Pseudomonas. In: Parker T, Leslie M, Collier H (eds) Principles of bacteriology, virology and immunology, vol 2, 8th edn. Edward Arnold, New York, pp 255-273
42. Rastegar Lari A, Alaghehbandan R, Akhlaghi L (2005) Burn wound infections and antimicrobial resistance in Tehran, Iran: an increasing problem. Ann Burns Fire Disasters 18:68-73
43. Rosenthal VD, Guzmán S, Crnich C (2004) Device-associated nosocomial infection rates in intensive care units of Argentina. Infect Control Hosp Epidemiol 25:251-255
44. Sevillano E, Valderrey C, Canduela MJ, Umaran A, Calvo F, Gallego L (2006) Resistance to antibiotics in clinical isolates of Pseudomonas aeruginosa. Pathol Biol 54:493-497
45. Shahcheraghi F, Nikbin VS, Feizabadi MM (2009) Prevalence of ESBLs genes among multidrug-resistant isolates of Pseudomonas aeruginosa isolated from patients in Tehran. Microb Drug Resist 15:37-39
46. Shahid M, Malik A (2005) Resistance due to aminoglycoside modifying enzymes in Pseudomonas aeruginosa isolates from burns patients. Indian J Med Res 122:324-329
47. Smith RD, Coast J (2002) Antimicrobial resistance: a global response. Bull World Health Organ 80:126-133
48. Spanik S, Lacka J, Koren P et al (1997) Increasing incidence of carbapenem-resistant Pseudomonas aeruginosa bacteraemia in a cancer centre over a seven-year period. J Hosp Infect 35:250-251
49. Suttajit S, Wagner AK, Tantipidoke R, Ross-Degnan D, Sitthi-amorn C (2005) Patterns, appropriateness, and predictors of antimicrobial prescribing for adults with upper respiratory infections in urban slum communities of Bangkok. Southeast Asian J Trop Med Public Health 36:489-497
50. Teres D, Schweers P, Bushnell LS, Hedley-Whyte J, Feingold DS (1973) Sources of Pseudomonas aeruginosa infection in a respiratory-surgical intensive-therapy unit. Lancet 1:415-417
51. Troillet N, Samore MH, Carmeli Y (1997) Imipenem-resistant Pseudomonas aeruginosa: risk factors and antibiotic susceptibility patterns. Clin Infect Dis 25:1094-1098
52. Turner P (2004) Susceptibility of meropenem and comparators tested against 30, 634 Enterobacteriaceae isolated in the MYSTIC Programme (1997-2003). Diagn Microbiol Infect Dis 50:291-293
53. Van Delden C, Iglewski BH (1998) Cell-to-cell signaling and Pseudomonas aeruginosa infections. Emerg Infect Dis 4:551-560
54. Van Eldere J (2003) Multicentre surveillance of Pseudomonas aeruginosa susceptibility patterns in nosocomial infections. J Antimicrob Chemother 51:347-352
55. Varaiya A, Kulkarni N, Kulkarni M, Bhalekar P, Dogra J (2008) Incidence of metallo beta lactamase producing Pseudomonas aeruginosa in ICU patients. Indian J Med Res 127:398-402
56. Vercauteren E, Descheemaeker P, Leven M, Sanders CC, Goossens H (1997) Comparison of screening methods for the detection of extended-spectrum beta-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital. J Clin Microbiol 35:2191-2197
57. Wattal C, Joshi S, Sharma A, Oberoi JK, Prasad KJ (2005) Prescription auditing and antimicrobial resistance at a tertiary care hospital in New Delhi, India. J Hosp Infect 59:156-158
58. Winn WC, Allen S, Janda W et al (2006) The non-fermentative Gramnegative bacilli. In: Colour atlas and textbook of diagnostic microbiology, 6th edn. Lippincott Williams & Wilkins, Philadelphia